michigan semaglutide digestive blockage class action Can GLP-1 Medications Be Considered for Weight Loss in Patients with APS? semaglutide gastric intestinal obstruction law

2025;25(1):10.1186/s12872-025-05278-3

For some patients, tirzepatide may support greater weight loss than semaglutide

placebo without baseline insulin. In pooled analyses, researchers found that treatment with any new diabetes drug but without insulin for type 2 diabetes was associated with CV benefit compared with placebo with no insulin at baseline (pooled RR = 0.85

Abbreviations used in the table: HepG2: human liver cancer cell line

These cases had a subtle onset and were accompanied by nonspecific symptoms such as malaise, myalgias, abdominal pain, respiratory distress, or increased somnolence

Dezsi L, Vecsei L